The project on the development of new sensitive biomarks for early diagnosis and a better classification of neuroendocrine tumours is well established and running accord to plan. The first patients with NETs have been included in a unique clinical trial with an Oncolytic virus that is only killing the tumour cells and respect normal cells. The results so far look very promising. We expect to get specimens from 35 patients.
Donation to Pan-Mass Challenge
The Pan-Mass Challenge is a fundraising bike-a-thon started in 1980 by Billy Starr to benefit the Dana-Farber Institute via the Jimmy Fund. From 1980 to 2019, the event has raised…
see project